Firm News: Drugs & Devices: Page 11

W&L Investigating Maquet’s TigerPaw System II Recall Cases

W&L has begun looking into the dangers of using the TigerPaw System II during occlusion of the heart’s left atrial appendage, a procedure sometimes performed in patients with atrial fibrillation to prevent blood clots from collecting and traveling to other parts of the body. The firm has discovered reports regarding the closure device reported in…

W&L Is Told 95% of Eligible Stryker Hip Patients Enrolled in Settlement

Nationally prominent personal injury law firm Weitz & Luxenberg, P.C., today said that 95 percent of registered eligible patients are now enrolled in the Stryker modular hip settlement program. This program has been established to ensure that each injured patient will receive a share of more than $1 billion as compensation for problems encountered with…

$2.4 Billion Settlement Reached in Actos Products Liability Litigation

Attorney Richard J. Arsenault of Neblett, Beard & Arsenault, and Paul J. Pennock of Weitz & Luxenberg, were the court-appointed co-lead Plaintiffs’ counsel in the Multi-District Litigation (MDL 2299) pending in Lafayette, Louisiana.  This settlement relates to legal actions filed beginning in 2011 in response to Plaintiffs diagnosed with bladder cancer as a result of…

W&L Accepting Zimmer Persona Knee Replacement Cases

A recent voluntary recall of the porous coated, uncemented Zimmer Persona Knee Trabecular Metal Tibial Plates, which the U.S. Food and Drug Administration (FDA) subsequently categorized as a Class II recall, has led Weitz & Luxenberg, P.C., to begin accepting cases involving Zimmer Persona Knee replacement injuries, the law firm today announced. The company that…

Get the Help You Need Today

Free Case Review